| |
Adimab
Avedro
Bar Harbor Biotechnology
GlycoFi
M2S |
M2S develops and markets FDA-approved advanced medical imaging software products and Medicare-reimbursable services for clinical diagnosis, monitoring and treatment, with a current focus on vascular disease, particularly Abdominal and Thoracic Aortic Aneurysms (AAA and TAA). With proprietary 3D-imaging technology and advanced metrics, M2S offers a complete solution to the challenges of AA disease management. |
M2S
12 Commerce Avenue
West Lebanon, NH 03784
www.m2s.com
M2S was acquired by Altaris Health Partners in 2005 |
|
